Safety pharmacology--current and emerging concepts.
Toxicol Appl Pharmacol
; 273(2): 229-41, 2013 Dec 01.
Article
em En
| MEDLINE
| ID: mdl-23732082
Palavras-chave
ADR; AKI; ALP; ALT; AP; AST; Adverse Drug Reaction; BP; BUN; CLU; CNS; CVS; Cardiovascular; Cardiovascular System; Central Nervous System; Central nervous system; ECG; EEG; EMA; Electrocardiogram; European Medicines Agency; FDA; FOB; Food and Drug Administration; Functional Observation Battery; GFR; GGT; GI; GST; Gastrointestinal; Glomerular Filtration Rate; HR; ICH; International Conference on Harmonisation; KIM-1; LDH; N-acetyl-ß-d-glucosaminidase; NCE; NGAL; NMR; Neutrophil gelatinase-associated lipocalin; New Chemical Entity; Nuclear Magnetic Resonance; PBPK; PEB; RPA-1; Respiratory; Risk; SP; Safety Pharmacology; Safety pharmacology; TFF3; VQM; Ventilation (V)/perfusion (Q) mismatch (M); action potential; acute kidney injury; alanine aminotransferase; alkaline phosphatase; aspartate aminotransferase; blood pressure; blood urea nitrogen; clusterin; electroencephalography; glutathione S transferase; hERG; hESC; heart rate; human Ether-a-go-go related gene; human embryonic stem cells; kidney injury molecule-1; lactate dehydrogenase; miR; microRNA; photoelectric beam interruption technique; physiologically based pharmacokinetics; renal papillary antigen-1; trefoil factor 3; ß-NAG; γ-glutamyl transferase
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Preparações Farmacêuticas
/
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos
/
Descoberta de Drogas
Tipo de estudo:
Guideline
/
Prognostic_studies
Limite:
Animals
/
Humans
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article